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tion and acute respiratory distress syndrome in 1 case. All patients 
except one post-operative infarction case were discharged on foot, 
and their mean hospital stay after operation was 12 days. No operative 
death was seen and the overall 90-day postoperative mortality rate was 
zero. Although the mean follow up period was 23 months, the overall 
survival rate was 67%, so far.
Conclusions: Postoperative complication rate after pulmonary artery 
reconstruction was relatively high, but most of the complications were 
controllable. Lobectomy assosicated with pulmonary artery reconstruc-
tion procedure for lung cancer treatment is useful and feasible, with 
good intermediate term results. 
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Systemic bilateral mediastinal dissection for c-N2 non small cell 
lung cancer
Yokota, Toshiya; Hata, Enjo; Ikeda, Shingo 
Mitsui Memorial Hospital, Chiyoda, Japan
Background: According to the study of regional lymphtic drainage, we 
considered reasonable lymphadenectomy contributes the post-operative 
survival of the patient with Non Small Cell Lung Cancer (NSCLC). 
And we had devised Systemic Bilateral Mediastinal Dissection and 
lung resection through a median sternotomy (ND3 operation) for 
patient with NSCLC. 
Material and Method: The patients with NSCLC who are estimated to 
be able to conventional radical operation and aged 75 year-old or less 
becomes the adaptation of ND3 operation. From Jan.1988 through Dec. 
2005, 264 patients of the left lung primary underwent ND3 operation 
and we reviewed 61 cases with c-N2 left primary NSCLC(excluding 
the patients with M1 disease).
Results: Overall 5-year survival rate in the 264 patients of left lung 
primary was 56.3%. Operative mortality in 264 patients was 4.0%, and 
in 112 patients who underwent ND3 operation from Jan.2000 through 
Dec.2005 was 1.8% .
In these c-N2(n=61) patients, over all ﬁve-year survival was 48.9%, 
and according to post-operative pathological stages were 100% in 
4 pts of p-stage IA, 68.6% in7 pts p-stagIB, 51.4% in 8 pts p-stage 
IIB,46.0% in 23 pts p-stageIIIA and 38.5% in 21 pts p-stageIIIB.
Conclusion: Our result suggested that the post-operative survival of 
patients with c-N2 NSCLC of the left lung primary would be remark-
ably improved by Systemic Bilateral Mediastinal Dissection. 
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Background: Japanese researchers have reported good correlation 
between radiologic and pathologic ﬁndings in early lung adenocarci-
nomas. For negative margin conﬁrmation, we found a technique using 
lavage and cytological examination.
Objectives: Conﬁrm limited resection efﬁcacy as radical surgery in 
patients with high resolution CT indicated minimally invasive lung 
cancer. Conﬁrm intraoperative cytology as a negative margin indicator 
and reliable margin non-recurrence predictor. 
Methods: Enrollment requires patients with a tumor ≤2 cm in diameter, 
diagnosed or suspected as a clinical T1N0M0 carcinoma in the lung 
periphery based on a CT scan. They had to have a high-resolution CT 
scan indicating a sub-solid nodule with tumor disappearance ratio; 
TDR ≥0.5. (TDR = 1- DM/DL; DM: maximum tumor diameter on 
mediastinal settings, DL: maximum tumor diameter on lung settings). 
Patients with a malignancy history within the past 5 years or those unﬁt 
for lobectomy and systematic lymph node dissection are excluded.
We perform a wedge or segmental resection. The used stapling car-
tridges are washed with 50 ml saline. Washing saline is centrifuged and 
sediment stained using Papanicolaou’s method and examined for cancer 
cells. If cytology is cancer positive, additional margin is resected, 
and cytologic examination repeated. If the second exam is positive, 
a routine lobectomy and systematic lymph node dissection will be 
performed.
Patients are followed up every 6 months by chest CT for the ﬁrst 3 
years, and annually thereafter for at least 5 years. The endpoint is 5 
year local recurrence free survival rate.
The Kanagawa Cancer Center joined the study in November 2006.
Results: This prospective study started in November 2003, and 35 
patients have been enrolled as of February 2007. This is 5.1% of all re-
sected lung cancer patients during this period. There were 12 men and 
23 women, aged 30-78, with an average 61 years. Tumor sizes ranged 
from 6 to 20 mm in the resected specimens, averaging 12 mm. There 
were 6 Noguchi type A tumors, 16 type B tumors, 9 type C tumors, 
one unclassiﬁable adenocarcinoma, and 3 inﬂammatory ﬁbroses. All 
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cancers showed no vessel invasion or positive cytology results. There 
was no correlation between tumor size, TDR, and subtype. No mortal-
ity or recurrence has occurred, but one patient developed postoperative 
pneumothorax.
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Introduction: Pancoast tumors are seen as a subgroup of lungcancer 
that behave differently from most other non small cell lungcancers. 
These tumors tend to behave more aggressively locally and metastasize 
more rapidly. Therefore their treatment should also be more aggressive. 
Our center’s experience with Pancoast tumors will be discussed and 
compared with current literature to asses the effects of induction 
chemoradiotherapy on the outcome. Based on these results a proposal 
for treatment will be advocated.
Methods: We retrospectively analyzed the records of all patients with 
Pancoast tumors treated with a multimodality approach at our institu-
tion from july 2001 through January 2007 and compared them with 
recent literature. 
Results: Twenty-six patients were in the study cohort. Because two 
patients failed to receive both chemotherapy and radiotherapy, we 
eventually included 24 patients (7 women, 17 men). The mean age was 
60 years (range, 40-78 years)
There were 18 patients with T3 tumors. 7 patients were proven N2 
positive after a positive PET scan and following mediastinoscopy. 
The chemotherapy regimens consisted of gemcitabine+carboplatin or 
etoposide+carboplatin. Chemotherapy was concurrently or sequentially 
given with external beam radiotherapy delivered in daily fractions 
for a total dose of 46 Gy in most patients. 7 patients with N2 disease 
underwent re-mediastinoscopy after completed induction therapy, with 
all proven negative N2 lymph nodes. 
Postoperative complications occurred in 8 patients (36 without any 
postoperative mortality. Although in 8 patients (36%) there was still vi-
able tumor in the pathologic specimen, we achieved complete resection 
in all patients but 1. There were no positive N2 nodes in the deﬁni-
tive pathologic specimen. In 2 patients with N2 positive nodes before 
induction therapy, there were postoperative positive N1 nodes in the 
specimen. Mean length of follow-up was 19 months (2-58). 6 patients 
died, 2 patients because of locoregional recurrence, 3 patients due to 
metastasis and 1 patient died of cardial cause. 4/12 patients with a fol-
low-up of more than two years died as a result of recurrent malignancy. 
Conclusions: Preoperative Chemo-Radiotherapy results in a high 
percentage of radical resections. Postoperative complications are more 
frequent. The subgroup of patients with a >2 year follow up show high 
survival rates of 66% especially when compared to patients in literature 
that have been treated with surgery alone. The overall results are 
comparable to results reported in literature. Tumor positive mediastinal 
lymph nodes before treatment should not necessarily exclude patients 
from trimodality treatment. The improved survival rates compared to 
surgery alone make this treatment the treatment of choice. 
Therefore we advocate that in this group of patients early multidisci-
plinary staging and organization of treatment is mandatory.
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Background: The aim of this study was to assess feasibility and ef-
ﬁcacy of neoajuvant chemotherapy with NVB and carboplatin followed 
surgery for patients with stage III NSCLC. 
Methods: We report 27 consecutive patients with all staged III NSCLC 
receiving neoadjuvant therapy. mean age was 62.1 years. Cell type was 
squamous 17 cases, adenocarcinoma 7 cases, adenosquamous 3 cases. 
Operations included pneumonectomy(10), pneumonectomy plus ca-
rino-resection(1), bilobectomy(2), lobectomy(10), lobectomy plus lung 
artery plastics(1), exploration(3). Chemotherapy was NP or NC for 1-2 
cycle before surgery. All patients were gived 4-6 cycles chemotherapy 
after operation.
Results: In this group, CR 1, PR 12, SD 13, PD 1.The rate of resection 
was 88.9%. 3 cases of exploration due to tumor invasive heart, cava 
venous. No surgical complication and mortality rate. Bleeding during 
operation was 150-4500ml. 
Conclusion: Destination of neoajuvant chemotherapy is down-stage, 
improving complete resection rate, killing micro-tumor of body, avoid-
ing relapse and distant metastasis, prolong survival and improving 
life quality of patients. Therefore, from our group and foreign papers, 
neoajuvant chemotherapy is safe, effective, not increasing surgical 
mortality and complication after operation.
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Purpose: To assess the results of the surgical treatment of patients with 
non-small cell lung cancer (NSCLC) invading the pulmonary vessels or 
atrium.
Methods: From November 1986 to December 2006, 49 patients 
underwent ñombined pneumonectomy with partial resection of the 
left atrium for lung cancer, without (n=41) and with cardiopulmonary 
bypass and reconstruction bovine pericardium graft (n=8).
Results: Of the 49 patients (median age of 58,6 years, range 41 to 75 
years), 47 were men (96%) and 2 were women. Pathologic analysis of 
the specimens identiﬁed 26 patients (53%) with N2 disease, 22 patients 
(45%) with N1 disease, and 1 patient with N0 disease. The T status 
was pT4 in 35 patients, pT3 in 14 patients. The myocard in border of 
resection was detected by microscopy. Histology was squamous cell 
carcinoma in 37 patients, adenocarcinoma in 4, large cell carcinoma 
in 2, mucoepidermoid carcinoma in 1 and adenoid cystic carcinoma in 
1. 8 patients received a preoperative chemotherapy (n = 2) or radio-
therapy (n = 6). 31 patients (63,2%) underwent right pneumonectomy. 
Only left atrium was resected in 34 patients, two organs in 10 patients, 
and three organs in 5 patient. The superior vena cava was resected in 2 
patients, muscular coat of esophagus in 3, the adventitia of the aorta in 
3, the trachea in 9, diaphragma in 1 and the pulmonary artery in 2. The 
operative mortality rate was 6,6% (n = 3). Non-fatal major complica-
tions occurred in 6 patients (12,2%). The survival rate, calculated with 
the Kaplan-Meier method, was estimated as 61% at 1 year, 36 % at 3 
years and 24% at 5 years (median 15 months), including the operative 
